nodes	percent_of_prediction	percent_of_DWPC	metapath
Lamotrigine—SCN5A—dilated cardiomyopathy	0.687	1	CbGaD
Lamotrigine—SCN5A—purkinje fiber—dilated cardiomyopathy	0.0376	0.452	CbGeAlD
Lamotrigine—ABCB1—Lisinopril—dilated cardiomyopathy	0.029	0.532	CbGbCtD
Lamotrigine—ABCB1—Spironolactone—dilated cardiomyopathy	0.0255	0.468	CbGbCtD
Lamotrigine—SCN5A—endocardium—dilated cardiomyopathy	0.0194	0.233	CbGeAlD
Lamotrigine—SCN5A—sinoatrial node—dilated cardiomyopathy	0.0184	0.221	CbGeAlD
Lamotrigine—SCN8A—Interaction between L1 and Ankyrins—SCN5A—dilated cardiomyopathy	0.00491	0.0673	CbGpPWpGaD
Lamotrigine—SCN9A—Interaction between L1 and Ankyrins—SCN5A—dilated cardiomyopathy	0.00397	0.0544	CbGpPWpGaD
Lamotrigine—SCN3A—Interaction between L1 and Ankyrins—SCN5A—dilated cardiomyopathy	0.0038	0.0521	CbGpPWpGaD
Lamotrigine—SCN4A—Interaction between L1 and Ankyrins—SCN5A—dilated cardiomyopathy	0.00365	0.05	CbGpPWpGaD
Lamotrigine—SCN2A—Interaction between L1 and Ankyrins—SCN5A—dilated cardiomyopathy	0.00365	0.05	CbGpPWpGaD
Lamotrigine—SCN1A—Interaction between L1 and Ankyrins—SCN5A—dilated cardiomyopathy	0.00352	0.0482	CbGpPWpGaD
Lamotrigine—SCN10A—Interaction between L1 and Ankyrins—SCN5A—dilated cardiomyopathy	0.00352	0.0482	CbGpPWpGaD
Lamotrigine—SCN8A—L1CAM interactions—SCN5A—dilated cardiomyopathy	0.00188	0.0258	CbGpPWpGaD
Lamotrigine—SCN5A—cardiac ventricle—dilated cardiomyopathy	0.00163	0.0196	CbGeAlD
Lamotrigine—SCN5A—myocardium—dilated cardiomyopathy	0.00153	0.0184	CbGeAlD
Lamotrigine—SCN5A—Cardiac Progenitor Differentiation—MYH6—dilated cardiomyopathy	0.00153	0.0209	CbGpPWpGaD
Lamotrigine—SCN9A—L1CAM interactions—SCN5A—dilated cardiomyopathy	0.00152	0.0209	CbGpPWpGaD
Lamotrigine—SCN3A—L1CAM interactions—SCN5A—dilated cardiomyopathy	0.00146	0.02	CbGpPWpGaD
Lamotrigine—SCN2A—L1CAM interactions—SCN5A—dilated cardiomyopathy	0.0014	0.0192	CbGpPWpGaD
Lamotrigine—SCN4A—L1CAM interactions—SCN5A—dilated cardiomyopathy	0.0014	0.0192	CbGpPWpGaD
Lamotrigine—SCN4A—heart—dilated cardiomyopathy	0.00138	0.0166	CbGeAlD
Lamotrigine—SCN5A—Cardiac Progenitor Differentiation—TNNI3—dilated cardiomyopathy	0.00136	0.0187	CbGpPWpGaD
Lamotrigine—SCN10A—L1CAM interactions—SCN5A—dilated cardiomyopathy	0.00135	0.0185	CbGpPWpGaD
Lamotrigine—SCN1A—L1CAM interactions—SCN5A—dilated cardiomyopathy	0.00135	0.0185	CbGpPWpGaD
Lamotrigine—SCN5A—Cardiac Progenitor Differentiation—TNNT2—dilated cardiomyopathy	0.00116	0.0159	CbGpPWpGaD
Lamotrigine—SCN5A—Cardiac Progenitor Differentiation—ACTC1—dilated cardiomyopathy	0.00116	0.0159	CbGpPWpGaD
Lamotrigine—Bursitis—Lisinopril—dilated cardiomyopathy	0.00115	0.0113	CcSEcCtD
Lamotrigine—SCN3A—heart—dilated cardiomyopathy	0.00107	0.0129	CbGeAlD
Lamotrigine—Renal failure acute—Spironolactone—dilated cardiomyopathy	0.00107	0.0105	CcSEcCtD
Lamotrigine—SCN5A—heart—dilated cardiomyopathy	0.00107	0.0129	CbGeAlD
Lamotrigine—Renal pain—Lisinopril—dilated cardiomyopathy	0.00106	0.0104	CcSEcCtD
Lamotrigine—Thrombosis—Furosemide—dilated cardiomyopathy	0.00105	0.0103	CcSEcCtD
Lamotrigine—Apathy—Furosemide—dilated cardiomyopathy	0.00104	0.0102	CcSEcCtD
Lamotrigine—Ear disorder—Lisinopril—dilated cardiomyopathy	0.00103	0.0101	CcSEcCtD
Lamotrigine—Flat affect—Furosemide—dilated cardiomyopathy	0.00103	0.0101	CcSEcCtD
Lamotrigine—Ataxia—Spironolactone—dilated cardiomyopathy	0.000932	0.00911	CcSEcCtD
Lamotrigine—SCN5A—cardiac atrium—dilated cardiomyopathy	0.000916	0.011	CbGeAlD
Lamotrigine—Toxic epidermal necrolysis—Spironolactone—dilated cardiomyopathy	0.000893	0.00873	CcSEcCtD
Lamotrigine—Gastritis—Spironolactone—dilated cardiomyopathy	0.000878	0.00858	CcSEcCtD
Lamotrigine—Eosinophilia—Spironolactone—dilated cardiomyopathy	0.000849	0.00829	CcSEcCtD
Lamotrigine—Drug interaction—Furosemide—dilated cardiomyopathy	0.000801	0.00783	CcSEcCtD
Lamotrigine—Erectile dysfunction—Spironolactone—dilated cardiomyopathy	0.000789	0.00771	CcSEcCtD
Lamotrigine—Drowsiness—Spironolactone—dilated cardiomyopathy	0.000764	0.00747	CcSEcCtD
Lamotrigine—Vasculitis—Furosemide—dilated cardiomyopathy	0.000761	0.00744	CcSEcCtD
Lamotrigine—Stevens-Johnson syndrome—Spironolactone—dilated cardiomyopathy	0.000758	0.0074	CcSEcCtD
Lamotrigine—Renal failure—Spironolactone—dilated cardiomyopathy	0.000751	0.00734	CcSEcCtD
Lamotrigine—Herpes zoster—Lisinopril—dilated cardiomyopathy	0.00074	0.00724	CcSEcCtD
Lamotrigine—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.000713	0.00697	CcSEcCtD
Lamotrigine—SCN8A—Axon guidance—SCN5A—dilated cardiomyopathy	0.000712	0.00976	CbGpPWpGaD
Lamotrigine—Aplastic anaemia—Furosemide—dilated cardiomyopathy	0.000698	0.00682	CcSEcCtD
Lamotrigine—Cramps of lower extremities—Furosemide—dilated cardiomyopathy	0.000683	0.00667	CcSEcCtD
Lamotrigine—Bladder pain—Furosemide—dilated cardiomyopathy	0.000672	0.00657	CcSEcCtD
Lamotrigine—Urine output increased—Furosemide—dilated cardiomyopathy	0.000672	0.00657	CcSEcCtD
Lamotrigine—SCN8A—Developmental Biology—ZIC3—dilated cardiomyopathy	0.00067	0.00919	CbGpPWpGaD
Lamotrigine—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.000649	0.00634	CcSEcCtD
Lamotrigine—Breast pain—Lisinopril—dilated cardiomyopathy	0.000639	0.00625	CcSEcCtD
Lamotrigine—Accidental injury—Lisinopril—dilated cardiomyopathy	0.00063	0.00616	CcSEcCtD
Lamotrigine—Thrombophlebitis—Furosemide—dilated cardiomyopathy	0.000623	0.00609	CcSEcCtD
Lamotrigine—Polyuria—Furosemide—dilated cardiomyopathy	0.000614	0.006	CcSEcCtD
Lamotrigine—Photosensitivity—Furosemide—dilated cardiomyopathy	0.000614	0.006	CcSEcCtD
Lamotrigine—Arthropathy—Lisinopril—dilated cardiomyopathy	0.000613	0.00599	CcSEcCtD
Lamotrigine—Cough increased—Lisinopril—dilated cardiomyopathy	0.000609	0.00595	CcSEcCtD
Lamotrigine—Alopecia—Spironolactone—dilated cardiomyopathy	0.000606	0.00592	CcSEcCtD
Lamotrigine—Deafness—Furosemide—dilated cardiomyopathy	0.000603	0.00589	CcSEcCtD
Lamotrigine—Drug interaction—Lisinopril—dilated cardiomyopathy	0.000601	0.00587	CcSEcCtD
Lamotrigine—Haemolytic anaemia—Furosemide—dilated cardiomyopathy	0.000598	0.00584	CcSEcCtD
Lamotrigine—Leukocytosis—Lisinopril—dilated cardiomyopathy	0.000593	0.0058	CcSEcCtD
Lamotrigine—SCN9A—Axon guidance—SCN5A—dilated cardiomyopathy	0.000576	0.0079	CbGpPWpGaD
Lamotrigine—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.000574	0.00561	CcSEcCtD
Lamotrigine—Dermatitis exfoliative—Furosemide—dilated cardiomyopathy	0.000572	0.00559	CcSEcCtD
Lamotrigine—Vasculitis—Lisinopril—dilated cardiomyopathy	0.000571	0.00558	CcSEcCtD
Lamotrigine—Thirst—Furosemide—dilated cardiomyopathy	0.000567	0.00554	CcSEcCtD
Lamotrigine—Dermatitis bullous—Furosemide—dilated cardiomyopathy	0.000564	0.00552	CcSEcCtD
Lamotrigine—Neck pain—Lisinopril—dilated cardiomyopathy	0.000564	0.00552	CcSEcCtD
Lamotrigine—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.000554	0.00541	CcSEcCtD
Lamotrigine—SCN3A—Axon guidance—SCN5A—dilated cardiomyopathy	0.000551	0.00755	CbGpPWpGaD
Lamotrigine—Cystitis noninfective—Lisinopril—dilated cardiomyopathy	0.000545	0.00532	CcSEcCtD
Lamotrigine—SCN9A—Developmental Biology—ZIC3—dilated cardiomyopathy	0.000542	0.00744	CbGpPWpGaD
Lamotrigine—Salivary hypersecretion—Lisinopril—dilated cardiomyopathy	0.000542	0.00529	CcSEcCtD
Lamotrigine—Malaise—Spironolactone—dilated cardiomyopathy	0.000538	0.00526	CcSEcCtD
Lamotrigine—Cystitis—Lisinopril—dilated cardiomyopathy	0.000538	0.00526	CcSEcCtD
Lamotrigine—Leukopenia—Spironolactone—dilated cardiomyopathy	0.000535	0.00522	CcSEcCtD
Lamotrigine—SCN4A—Axon guidance—SCN5A—dilated cardiomyopathy	0.000529	0.00726	CbGpPWpGaD
Lamotrigine—SCN2A—Axon guidance—SCN5A—dilated cardiomyopathy	0.000529	0.00726	CbGpPWpGaD
Lamotrigine—Photophobia—Lisinopril—dilated cardiomyopathy	0.000524	0.00512	CcSEcCtD
Lamotrigine—SCN3A—Developmental Biology—ZIC3—dilated cardiomyopathy	0.000519	0.00711	CbGpPWpGaD
Lamotrigine—Irritability—Furosemide—dilated cardiomyopathy	0.000515	0.00503	CcSEcCtD
Lamotrigine—Urinary retention—Furosemide—dilated cardiomyopathy	0.000513	0.00501	CcSEcCtD
Lamotrigine—SCN1A—Axon guidance—SCN5A—dilated cardiomyopathy	0.00051	0.007	CbGpPWpGaD
Lamotrigine—SCN10A—Axon guidance—SCN5A—dilated cardiomyopathy	0.00051	0.007	CbGpPWpGaD
Lamotrigine—SCN8A—Developmental Biology—SCN5A—dilated cardiomyopathy	0.000508	0.00697	CbGpPWpGaD
Lamotrigine—Bladder pain—Lisinopril—dilated cardiomyopathy	0.000504	0.00493	CcSEcCtD
Lamotrigine—Discomfort—Spironolactone—dilated cardiomyopathy	0.000502	0.00491	CcSEcCtD
Lamotrigine—SCN2A—Developmental Biology—ZIC3—dilated cardiomyopathy	0.000498	0.00683	CbGpPWpGaD
Lamotrigine—SCN4A—Developmental Biology—ZIC3—dilated cardiomyopathy	0.000498	0.00683	CbGpPWpGaD
Lamotrigine—SCN8A—L1CAM interactions—ITGB1—dilated cardiomyopathy	0.000497	0.00681	CbGpPWpGaD
Lamotrigine—Orthostatic hypotension—Furosemide—dilated cardiomyopathy	0.000493	0.00482	CcSEcCtD
Lamotrigine—Confusional state—Spironolactone—dilated cardiomyopathy	0.000491	0.0048	CcSEcCtD
Lamotrigine—Hypertonia—Lisinopril—dilated cardiomyopathy	0.000489	0.00478	CcSEcCtD
Lamotrigine—Toxic epidermal necrolysis—Furosemide—dilated cardiomyopathy	0.000486	0.00475	CcSEcCtD
Lamotrigine—SCN10A—Developmental Biology—ZIC3—dilated cardiomyopathy	0.00048	0.00659	CbGpPWpGaD
Lamotrigine—SCN1A—Developmental Biology—ZIC3—dilated cardiomyopathy	0.00048	0.00659	CbGpPWpGaD
Lamotrigine—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.000477	0.00466	CcSEcCtD
Lamotrigine—Muscular weakness—Furosemide—dilated cardiomyopathy	0.000476	0.00465	CcSEcCtD
Lamotrigine—Abdominal distension—Furosemide—dilated cardiomyopathy	0.000469	0.00459	CcSEcCtD
Lamotrigine—Sleep disorder—Lisinopril—dilated cardiomyopathy	0.000468	0.00457	CcSEcCtD
Lamotrigine—Eosinophilia—Furosemide—dilated cardiomyopathy	0.000462	0.00451	CcSEcCtD
Lamotrigine—Photosensitivity—Lisinopril—dilated cardiomyopathy	0.000461	0.00451	CcSEcCtD
Lamotrigine—SCN5A—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	0.000459	0.00629	CbGpPWpGaD
Lamotrigine—Pancreatitis—Furosemide—dilated cardiomyopathy	0.000457	0.00447	CcSEcCtD
Lamotrigine—Eczema—Lisinopril—dilated cardiomyopathy	0.00045	0.0044	CcSEcCtD
Lamotrigine—Hepatic failure—Lisinopril—dilated cardiomyopathy	0.00045	0.0044	CcSEcCtD
Lamotrigine—Haemolytic anaemia—Lisinopril—dilated cardiomyopathy	0.000448	0.00438	CcSEcCtD
Lamotrigine—Nasal congestion—Lisinopril—dilated cardiomyopathy	0.000444	0.00434	CcSEcCtD
Lamotrigine—ABCB1—ABC-family proteins mediated transport—ABCC9—dilated cardiomyopathy	0.000443	0.00608	CbGpPWpGaD
Lamotrigine—Injury—Lisinopril—dilated cardiomyopathy	0.00044	0.0043	CcSEcCtD
Lamotrigine—Renal failure acute—Lisinopril—dilated cardiomyopathy	0.000438	0.00428	CcSEcCtD
Lamotrigine—Libido decreased—Lisinopril—dilated cardiomyopathy	0.000436	0.00427	CcSEcCtD
Lamotrigine—Somnolence—Spironolactone—dilated cardiomyopathy	0.000433	0.00423	CcSEcCtD
Lamotrigine—Pollakiuria—Furosemide—dilated cardiomyopathy	0.000431	0.00421	CcSEcCtD
Lamotrigine—Atrial fibrillation—Lisinopril—dilated cardiomyopathy	0.000427	0.00417	CcSEcCtD
Lamotrigine—Photosensitivity reaction—Furosemide—dilated cardiomyopathy	0.000426	0.00416	CcSEcCtD
Lamotrigine—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.000421	0.00411	CcSEcCtD
Lamotrigine—Hyperglycaemia—Furosemide—dilated cardiomyopathy	0.000421	0.00411	CcSEcCtD
Lamotrigine—Arthritis—Lisinopril—dilated cardiomyopathy	0.000416	0.00407	CcSEcCtD
Lamotrigine—Drowsiness—Furosemide—dilated cardiomyopathy	0.000416	0.00406	CcSEcCtD
Lamotrigine—Cerebrovascular accident—Lisinopril—dilated cardiomyopathy	0.000413	0.00404	CcSEcCtD
Lamotrigine—Stevens-Johnson syndrome—Furosemide—dilated cardiomyopathy	0.000412	0.00403	CcSEcCtD
Lamotrigine—SCN9A—Developmental Biology—SCN5A—dilated cardiomyopathy	0.000411	0.00564	CbGpPWpGaD
Lamotrigine—Renal failure—Furosemide—dilated cardiomyopathy	0.000409	0.00399	CcSEcCtD
Lamotrigine—Osteoarthritis—Lisinopril—dilated cardiomyopathy	0.000405	0.00396	CcSEcCtD
Lamotrigine—Diplopia—Lisinopril—dilated cardiomyopathy	0.000405	0.00396	CcSEcCtD
Lamotrigine—SCN9A—L1CAM interactions—ITGB1—dilated cardiomyopathy	0.000402	0.00551	CbGpPWpGaD
Lamotrigine—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.000402	0.00393	CcSEcCtD
Lamotrigine—Disturbance in sexual arousal—Lisinopril—dilated cardiomyopathy	0.000402	0.00392	CcSEcCtD
Lamotrigine—SCN8A—L1CAM interactions—RAC1—dilated cardiomyopathy	0.000399	0.00548	CbGpPWpGaD
Lamotrigine—Sweating—Furosemide—dilated cardiomyopathy	0.000399	0.0039	CcSEcCtD
Lamotrigine—SCN3A—Developmental Biology—SCN5A—dilated cardiomyopathy	0.000393	0.00539	CbGpPWpGaD
Lamotrigine—Face oedema—Lisinopril—dilated cardiomyopathy	0.000391	0.00382	CcSEcCtD
Lamotrigine—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.000388	0.00379	CcSEcCtD
Lamotrigine—Urticaria—Spironolactone—dilated cardiomyopathy	0.000387	0.00378	CcSEcCtD
Lamotrigine—Irritability—Lisinopril—dilated cardiomyopathy	0.000386	0.00378	CcSEcCtD
Lamotrigine—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.000385	0.00377	CcSEcCtD
Lamotrigine—Cardiac arrest—Lisinopril—dilated cardiomyopathy	0.000385	0.00376	CcSEcCtD
Lamotrigine—SCN3A—L1CAM interactions—ITGB1—dilated cardiomyopathy	0.000384	0.00527	CbGpPWpGaD
Lamotrigine—Ataxia—Lisinopril—dilated cardiomyopathy	0.000381	0.00372	CcSEcCtD
Lamotrigine—SCN4A—Developmental Biology—SCN5A—dilated cardiomyopathy	0.000378	0.00518	CbGpPWpGaD
Lamotrigine—SCN2A—Developmental Biology—SCN5A—dilated cardiomyopathy	0.000378	0.00518	CbGpPWpGaD
Lamotrigine—Orthostatic hypotension—Lisinopril—dilated cardiomyopathy	0.00037	0.00361	CcSEcCtD
Lamotrigine—SCN2A—L1CAM interactions—ITGB1—dilated cardiomyopathy	0.000369	0.00506	CbGpPWpGaD
Lamotrigine—SCN4A—L1CAM interactions—ITGB1—dilated cardiomyopathy	0.000369	0.00506	CbGpPWpGaD
Lamotrigine—Toxic epidermal necrolysis—Lisinopril—dilated cardiomyopathy	0.000364	0.00356	CcSEcCtD
Lamotrigine—SCN1A—Developmental Biology—SCN5A—dilated cardiomyopathy	0.000364	0.00499	CbGpPWpGaD
Lamotrigine—SCN10A—Developmental Biology—SCN5A—dilated cardiomyopathy	0.000364	0.00499	CbGpPWpGaD
Lamotrigine—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.000359	0.00351	CcSEcCtD
Lamotrigine—Gastritis—Lisinopril—dilated cardiomyopathy	0.000358	0.0035	CcSEcCtD
Lamotrigine—SCN1A—L1CAM interactions—ITGB1—dilated cardiomyopathy	0.000356	0.00488	CbGpPWpGaD
Lamotrigine—SCN10A—L1CAM interactions—ITGB1—dilated cardiomyopathy	0.000356	0.00488	CbGpPWpGaD
Lamotrigine—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.000353	0.00345	CcSEcCtD
Lamotrigine—Asthma—Lisinopril—dilated cardiomyopathy	0.00035	0.00342	CcSEcCtD
Lamotrigine—Influenza—Lisinopril—dilated cardiomyopathy	0.00035	0.00342	CcSEcCtD
Lamotrigine—Eye disorder—Furosemide—dilated cardiomyopathy	0.000349	0.00341	CcSEcCtD
Lamotrigine—Tinnitus—Furosemide—dilated cardiomyopathy	0.000348	0.0034	CcSEcCtD
Lamotrigine—Eosinophilia—Lisinopril—dilated cardiomyopathy	0.000346	0.00339	CcSEcCtD
Lamotrigine—Pruritus—Spironolactone—dilated cardiomyopathy	0.000345	0.00337	CcSEcCtD
Lamotrigine—Bronchospasm—Lisinopril—dilated cardiomyopathy	0.000344	0.00336	CcSEcCtD
Lamotrigine—Pancreatitis—Lisinopril—dilated cardiomyopathy	0.000343	0.00335	CcSEcCtD
Lamotrigine—Angina pectoris—Lisinopril—dilated cardiomyopathy	0.000341	0.00333	CcSEcCtD
Lamotrigine—Angiopathy—Furosemide—dilated cardiomyopathy	0.000339	0.00331	CcSEcCtD
Lamotrigine—SCN5A—Developmental Biology—ZIC3—dilated cardiomyopathy	0.000338	0.00463	CbGpPWpGaD
Lamotrigine—Bronchitis—Lisinopril—dilated cardiomyopathy	0.000336	0.00329	CcSEcCtD
Lamotrigine—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.000333	0.00326	CcSEcCtD
Lamotrigine—Pancytopenia—Lisinopril—dilated cardiomyopathy	0.000332	0.00325	CcSEcCtD
Lamotrigine—Dysuria—Lisinopril—dilated cardiomyopathy	0.000327	0.0032	CcSEcCtD
Lamotrigine—Neutropenia—Lisinopril—dilated cardiomyopathy	0.000327	0.0032	CcSEcCtD
Lamotrigine—Malnutrition—Furosemide—dilated cardiomyopathy	0.000325	0.00318	CcSEcCtD
Lamotrigine—Erythema—Furosemide—dilated cardiomyopathy	0.000325	0.00318	CcSEcCtD
Lamotrigine—SCN9A—L1CAM interactions—RAC1—dilated cardiomyopathy	0.000323	0.00443	CbGpPWpGaD
Lamotrigine—Dizziness—Spironolactone—dilated cardiomyopathy	0.000322	0.00315	CcSEcCtD
Lamotrigine—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.000322	0.00315	CcSEcCtD
Lamotrigine—Flatulence—Furosemide—dilated cardiomyopathy	0.00032	0.00313	CcSEcCtD
Lamotrigine—Photosensitivity reaction—Lisinopril—dilated cardiomyopathy	0.000319	0.00312	CcSEcCtD
Lamotrigine—Weight increased—Lisinopril—dilated cardiomyopathy	0.000318	0.00311	CcSEcCtD
Lamotrigine—Dysgeusia—Furosemide—dilated cardiomyopathy	0.000318	0.00311	CcSEcCtD
Lamotrigine—Weight decreased—Lisinopril—dilated cardiomyopathy	0.000316	0.00309	CcSEcCtD
Lamotrigine—Hyperglycaemia—Lisinopril—dilated cardiomyopathy	0.000316	0.00308	CcSEcCtD
Lamotrigine—Pneumonia—Lisinopril—dilated cardiomyopathy	0.000314	0.00307	CcSEcCtD
Lamotrigine—Muscle spasms—Furosemide—dilated cardiomyopathy	0.000312	0.00305	CcSEcCtD
Lamotrigine—Depression—Lisinopril—dilated cardiomyopathy	0.000311	0.00304	CcSEcCtD
Lamotrigine—Vomiting—Spironolactone—dilated cardiomyopathy	0.00031	0.00303	CcSEcCtD
Lamotrigine—Stevens-Johnson syndrome—Lisinopril—dilated cardiomyopathy	0.000309	0.00302	CcSEcCtD
Lamotrigine—SCN3A—L1CAM interactions—RAC1—dilated cardiomyopathy	0.000309	0.00424	CbGpPWpGaD
Lamotrigine—Acute coronary syndrome—Lisinopril—dilated cardiomyopathy	0.000307	0.00301	CcSEcCtD
Lamotrigine—Rash—Spironolactone—dilated cardiomyopathy	0.000307	0.003	CcSEcCtD
Lamotrigine—Dermatitis—Spironolactone—dilated cardiomyopathy	0.000307	0.003	CcSEcCtD
Lamotrigine—Renal failure—Lisinopril—dilated cardiomyopathy	0.000307	0.003	CcSEcCtD
Lamotrigine—Vision blurred—Furosemide—dilated cardiomyopathy	0.000306	0.00299	CcSEcCtD
Lamotrigine—Myocardial infarction—Lisinopril—dilated cardiomyopathy	0.000306	0.00299	CcSEcCtD
Lamotrigine—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.000306	0.00299	CcSEcCtD
Lamotrigine—Headache—Spironolactone—dilated cardiomyopathy	0.000305	0.00298	CcSEcCtD
Lamotrigine—Urinary tract infection—Lisinopril—dilated cardiomyopathy	0.000303	0.00296	CcSEcCtD
Lamotrigine—Anaemia—Furosemide—dilated cardiomyopathy	0.0003	0.00293	CcSEcCtD
Lamotrigine—SCN8A—Axon guidance—PSEN2—dilated cardiomyopathy	0.0003	0.00412	CbGpPWpGaD
Lamotrigine—Sweating—Lisinopril—dilated cardiomyopathy	0.000299	0.00292	CcSEcCtD
Lamotrigine—Agitation—Furosemide—dilated cardiomyopathy	0.000299	0.00292	CcSEcCtD
Lamotrigine—Haematuria—Lisinopril—dilated cardiomyopathy	0.000297	0.00291	CcSEcCtD
Lamotrigine—SCN4A—L1CAM interactions—RAC1—dilated cardiomyopathy	0.000297	0.00407	CbGpPWpGaD
Lamotrigine—SCN2A—L1CAM interactions—RAC1—dilated cardiomyopathy	0.000297	0.00407	CbGpPWpGaD
Lamotrigine—Epistaxis—Lisinopril—dilated cardiomyopathy	0.000294	0.00288	CcSEcCtD
Lamotrigine—Sinusitis—Lisinopril—dilated cardiomyopathy	0.000293	0.00286	CcSEcCtD
Lamotrigine—Vertigo—Furosemide—dilated cardiomyopathy	0.000292	0.00285	CcSEcCtD
Lamotrigine—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.000291	0.00284	CcSEcCtD
Lamotrigine—Leukopenia—Furosemide—dilated cardiomyopathy	0.000291	0.00284	CcSEcCtD
Lamotrigine—Nausea—Spironolactone—dilated cardiomyopathy	0.000289	0.00283	CcSEcCtD
Lamotrigine—ABCB1—heart—dilated cardiomyopathy	0.000289	0.00347	CbGeAlD
Lamotrigine—SCN10A—L1CAM interactions—RAC1—dilated cardiomyopathy	0.000286	0.00393	CbGpPWpGaD
Lamotrigine—SCN1A—L1CAM interactions—RAC1—dilated cardiomyopathy	0.000286	0.00393	CbGpPWpGaD
Lamotrigine—Rhinitis—Lisinopril—dilated cardiomyopathy	0.000281	0.00274	CcSEcCtD
Lamotrigine—Hepatitis—Lisinopril—dilated cardiomyopathy	0.00028	0.00274	CcSEcCtD
Lamotrigine—Hallucination—Lisinopril—dilated cardiomyopathy	0.000279	0.00272	CcSEcCtD
Lamotrigine—Pharyngitis—Lisinopril—dilated cardiomyopathy	0.000278	0.00272	CcSEcCtD
Lamotrigine—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.000276	0.0027	CcSEcCtD
Lamotrigine—Dry mouth—Furosemide—dilated cardiomyopathy	0.00027	0.00264	CcSEcCtD
Lamotrigine—Confusional state—Furosemide—dilated cardiomyopathy	0.000267	0.00261	CcSEcCtD
Lamotrigine—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.000265	0.00259	CcSEcCtD
Lamotrigine—Tinnitus—Lisinopril—dilated cardiomyopathy	0.000261	0.00255	CcSEcCtD
Lamotrigine—Shock—Furosemide—dilated cardiomyopathy	0.000261	0.00255	CcSEcCtD
Lamotrigine—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.00026	0.00254	CcSEcCtD
Lamotrigine—Flushing—Lisinopril—dilated cardiomyopathy	0.00026	0.00254	CcSEcCtD
Lamotrigine—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.00026	0.00254	CcSEcCtD
Lamotrigine—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.000256	0.00251	CcSEcCtD
Lamotrigine—Angiopathy—Lisinopril—dilated cardiomyopathy	0.000254	0.00248	CcSEcCtD
Lamotrigine—Anorexia—Furosemide—dilated cardiomyopathy	0.000253	0.00247	CcSEcCtD
Lamotrigine—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.000252	0.00247	CcSEcCtD
Lamotrigine—Chills—Lisinopril—dilated cardiomyopathy	0.000251	0.00246	CcSEcCtD
Lamotrigine—SCN5A—L1CAM interactions—ITGB1—dilated cardiomyopathy	0.00025	0.00343	CbGpPWpGaD
Lamotrigine—Alopecia—Lisinopril—dilated cardiomyopathy	0.000247	0.00242	CcSEcCtD
Lamotrigine—Mental disorder—Lisinopril—dilated cardiomyopathy	0.000245	0.0024	CcSEcCtD
Lamotrigine—Erythema—Lisinopril—dilated cardiomyopathy	0.000244	0.00238	CcSEcCtD
Lamotrigine—Malnutrition—Lisinopril—dilated cardiomyopathy	0.000244	0.00238	CcSEcCtD
Lamotrigine—SCN9A—Axon guidance—PSEN2—dilated cardiomyopathy	0.000243	0.00333	CbGpPWpGaD
Lamotrigine—Flatulence—Lisinopril—dilated cardiomyopathy	0.00024	0.00235	CcSEcCtD
Lamotrigine—Tension—Lisinopril—dilated cardiomyopathy	0.000239	0.00234	CcSEcCtD
Lamotrigine—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.000239	0.00233	CcSEcCtD
Lamotrigine—Paraesthesia—Furosemide—dilated cardiomyopathy	0.000238	0.00233	CcSEcCtD
Lamotrigine—Nervousness—Lisinopril—dilated cardiomyopathy	0.000237	0.00231	CcSEcCtD
Lamotrigine—Back pain—Lisinopril—dilated cardiomyopathy	0.000236	0.0023	CcSEcCtD
Lamotrigine—Somnolence—Furosemide—dilated cardiomyopathy	0.000236	0.0023	CcSEcCtD
Lamotrigine—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.000234	0.00229	CcSEcCtD
Lamotrigine—SCN3A—Axon guidance—PSEN2—dilated cardiomyopathy	0.000232	0.00318	CbGpPWpGaD
Lamotrigine—Decreased appetite—Furosemide—dilated cardiomyopathy	0.00023	0.00225	CcSEcCtD
Lamotrigine—Vision blurred—Lisinopril—dilated cardiomyopathy	0.00023	0.00225	CcSEcCtD
Lamotrigine—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.000229	0.00224	CcSEcCtD
Lamotrigine—Fatigue—Furosemide—dilated cardiomyopathy	0.000229	0.00223	CcSEcCtD
Lamotrigine—Tremor—Lisinopril—dilated cardiomyopathy	0.000228	0.00223	CcSEcCtD
Lamotrigine—Constipation—Furosemide—dilated cardiomyopathy	0.000227	0.00222	CcSEcCtD
Lamotrigine—Pain—Furosemide—dilated cardiomyopathy	0.000227	0.00222	CcSEcCtD
Lamotrigine—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.000226	0.00221	CcSEcCtD
Lamotrigine—Anaemia—Lisinopril—dilated cardiomyopathy	0.000225	0.0022	CcSEcCtD
Lamotrigine—SCN4A—Axon guidance—PSEN2—dilated cardiomyopathy	0.000223	0.00306	CbGpPWpGaD
Lamotrigine—SCN2A—Axon guidance—PSEN2—dilated cardiomyopathy	0.000223	0.00306	CbGpPWpGaD
Lamotrigine—Angioedema—Lisinopril—dilated cardiomyopathy	0.000223	0.00218	CcSEcCtD
Lamotrigine—Malaise—Lisinopril—dilated cardiomyopathy	0.00022	0.00215	CcSEcCtD
Lamotrigine—Vertigo—Lisinopril—dilated cardiomyopathy	0.000219	0.00214	CcSEcCtD
Lamotrigine—Syncope—Lisinopril—dilated cardiomyopathy	0.000219	0.00214	CcSEcCtD
Lamotrigine—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.000218	0.00214	CcSEcCtD
Lamotrigine—Leukopenia—Lisinopril—dilated cardiomyopathy	0.000218	0.00213	CcSEcCtD
Lamotrigine—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.000217	0.00212	CcSEcCtD
Lamotrigine—Palpitations—Lisinopril—dilated cardiomyopathy	0.000215	0.00211	CcSEcCtD
Lamotrigine—SCN1A—Axon guidance—PSEN2—dilated cardiomyopathy	0.000215	0.00295	CbGpPWpGaD
Lamotrigine—SCN10A—Axon guidance—PSEN2—dilated cardiomyopathy	0.000215	0.00295	CbGpPWpGaD
Lamotrigine—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.000214	0.00209	CcSEcCtD
Lamotrigine—SCN8A—Developmental Biology—PSEN2—dilated cardiomyopathy	0.000214	0.00294	CbGpPWpGaD
Lamotrigine—Cough—Lisinopril—dilated cardiomyopathy	0.000213	0.00208	CcSEcCtD
Lamotrigine—Urticaria—Furosemide—dilated cardiomyopathy	0.000211	0.00206	CcSEcCtD
Lamotrigine—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00021	0.00205	CcSEcCtD
Lamotrigine—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00021	0.00205	CcSEcCtD
Lamotrigine—Myalgia—Lisinopril—dilated cardiomyopathy	0.000208	0.00203	CcSEcCtD
Lamotrigine—Chest pain—Lisinopril—dilated cardiomyopathy	0.000208	0.00203	CcSEcCtD
Lamotrigine—Arthralgia—Lisinopril—dilated cardiomyopathy	0.000208	0.00203	CcSEcCtD
Lamotrigine—Anxiety—Lisinopril—dilated cardiomyopathy	0.000207	0.00202	CcSEcCtD
Lamotrigine—UGT1A4—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	0.000207	0.00284	CbGpPWpGaD
Lamotrigine—Discomfort—Lisinopril—dilated cardiomyopathy	0.000205	0.002	CcSEcCtD
Lamotrigine—Dry mouth—Lisinopril—dilated cardiomyopathy	0.000203	0.00198	CcSEcCtD
Lamotrigine—SCN5A—L1CAM interactions—RAC1—dilated cardiomyopathy	0.000201	0.00276	CbGpPWpGaD
Lamotrigine—Confusional state—Lisinopril—dilated cardiomyopathy	0.000201	0.00196	CcSEcCtD
Lamotrigine—Oedema—Lisinopril—dilated cardiomyopathy	0.000199	0.00194	CcSEcCtD
Lamotrigine—Infection—Lisinopril—dilated cardiomyopathy	0.000198	0.00193	CcSEcCtD
Lamotrigine—UGT1A4—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	0.000197	0.0027	CbGpPWpGaD
Lamotrigine—Shock—Lisinopril—dilated cardiomyopathy	0.000196	0.00191	CcSEcCtD
Lamotrigine—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.000195	0.00191	CcSEcCtD
Lamotrigine—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.000195	0.0019	CcSEcCtD
Lamotrigine—Tachycardia—Lisinopril—dilated cardiomyopathy	0.000194	0.0019	CcSEcCtD
Lamotrigine—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.000192	0.00188	CcSEcCtD
Lamotrigine—Asthenia—Furosemide—dilated cardiomyopathy	0.00019	0.00186	CcSEcCtD
Lamotrigine—Anorexia—Lisinopril—dilated cardiomyopathy	0.00019	0.00185	CcSEcCtD
Lamotrigine—SCN8A—Axon guidance—ITGB1—dilated cardiomyopathy	0.000188	0.00257	CbGpPWpGaD
Lamotrigine—Pruritus—Furosemide—dilated cardiomyopathy	0.000188	0.00183	CcSEcCtD
Lamotrigine—SCN8A—L1CAM interactions—EGFR—dilated cardiomyopathy	0.000182	0.00249	CbGpPWpGaD
Lamotrigine—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000181	0.00177	CcSEcCtD
Lamotrigine—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.000181	0.00177	CcSEcCtD
Lamotrigine—Insomnia—Lisinopril—dilated cardiomyopathy	0.00018	0.00176	CcSEcCtD
Lamotrigine—SCN5A—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.000179	0.00246	CbGpPWpGaD
Lamotrigine—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.000179	0.00175	CcSEcCtD
Lamotrigine—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.000177	0.00173	CcSEcCtD
Lamotrigine—Somnolence—Lisinopril—dilated cardiomyopathy	0.000177	0.00173	CcSEcCtD
Lamotrigine—Dizziness—Furosemide—dilated cardiomyopathy	0.000175	0.00171	CcSEcCtD
Lamotrigine—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.000175	0.00171	CcSEcCtD
Lamotrigine—SCN9A—Developmental Biology—PSEN2—dilated cardiomyopathy	0.000173	0.00238	CbGpPWpGaD
Lamotrigine—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.000173	0.00169	CcSEcCtD
Lamotrigine—UGT1A3—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	0.000172	0.00236	CbGpPWpGaD
Lamotrigine—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.000172	0.00168	CcSEcCtD
Lamotrigine—Fatigue—Lisinopril—dilated cardiomyopathy	0.000172	0.00168	CcSEcCtD
Lamotrigine—Pain—Lisinopril—dilated cardiomyopathy	0.00017	0.00166	CcSEcCtD
Lamotrigine—Constipation—Lisinopril—dilated cardiomyopathy	0.00017	0.00166	CcSEcCtD
Lamotrigine—Vomiting—Furosemide—dilated cardiomyopathy	0.000169	0.00165	CcSEcCtD
Lamotrigine—Rash—Furosemide—dilated cardiomyopathy	0.000167	0.00163	CcSEcCtD
Lamotrigine—Dermatitis—Furosemide—dilated cardiomyopathy	0.000167	0.00163	CcSEcCtD
Lamotrigine—Headache—Furosemide—dilated cardiomyopathy	0.000166	0.00162	CcSEcCtD
Lamotrigine—SCN3A—Developmental Biology—PSEN2—dilated cardiomyopathy	0.000166	0.00227	CbGpPWpGaD
Lamotrigine—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000164	0.0016	CcSEcCtD
Lamotrigine—UGT1A3—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	0.000164	0.00224	CbGpPWpGaD
Lamotrigine—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.000163	0.00159	CcSEcCtD
Lamotrigine—SCN2A—Developmental Biology—PSEN2—dilated cardiomyopathy	0.000159	0.00218	CbGpPWpGaD
Lamotrigine—SCN4A—Developmental Biology—PSEN2—dilated cardiomyopathy	0.000159	0.00218	CbGpPWpGaD
Lamotrigine—Urticaria—Lisinopril—dilated cardiomyopathy	0.000158	0.00154	CcSEcCtD
Lamotrigine—Nausea—Furosemide—dilated cardiomyopathy	0.000157	0.00154	CcSEcCtD
Lamotrigine—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000157	0.00154	CcSEcCtD
Lamotrigine—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.000157	0.00154	CcSEcCtD
Lamotrigine—SCN5A—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.000155	0.00213	CbGpPWpGaD
Lamotrigine—SCN10A—Developmental Biology—PSEN2—dilated cardiomyopathy	0.000153	0.0021	CbGpPWpGaD
Lamotrigine—SCN1A—Developmental Biology—PSEN2—dilated cardiomyopathy	0.000153	0.0021	CbGpPWpGaD
Lamotrigine—SCN9A—Axon guidance—ITGB1—dilated cardiomyopathy	0.000152	0.00208	CbGpPWpGaD
Lamotrigine—SCN5A—Axon guidance—PSEN2—dilated cardiomyopathy	0.000151	0.00207	CbGpPWpGaD
Lamotrigine—SCN8A—Axon guidance—RAC1—dilated cardiomyopathy	0.000151	0.00207	CbGpPWpGaD
Lamotrigine—SCN9A—L1CAM interactions—EGFR—dilated cardiomyopathy	0.000147	0.00201	CbGpPWpGaD
Lamotrigine—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.000147	0.00143	CcSEcCtD
Lamotrigine—SCN3A—Axon guidance—ITGB1—dilated cardiomyopathy	0.000145	0.00199	CbGpPWpGaD
Lamotrigine—Asthenia—Lisinopril—dilated cardiomyopathy	0.000143	0.00139	CcSEcCtD
Lamotrigine—Pruritus—Lisinopril—dilated cardiomyopathy	0.000141	0.00138	CcSEcCtD
Lamotrigine—SCN3A—L1CAM interactions—EGFR—dilated cardiomyopathy	0.00014	0.00193	CbGpPWpGaD
Lamotrigine—SCN2A—Axon guidance—ITGB1—dilated cardiomyopathy	0.00014	0.00191	CbGpPWpGaD
Lamotrigine—SCN4A—Axon guidance—ITGB1—dilated cardiomyopathy	0.00014	0.00191	CbGpPWpGaD
Lamotrigine—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000136	0.00133	CcSEcCtD
Lamotrigine—SCN2A—L1CAM interactions—EGFR—dilated cardiomyopathy	0.000135	0.00185	CbGpPWpGaD
Lamotrigine—SCN4A—L1CAM interactions—EGFR—dilated cardiomyopathy	0.000135	0.00185	CbGpPWpGaD
Lamotrigine—SCN10A—Axon guidance—ITGB1—dilated cardiomyopathy	0.000135	0.00185	CbGpPWpGaD
Lamotrigine—SCN1A—Axon guidance—ITGB1—dilated cardiomyopathy	0.000135	0.00185	CbGpPWpGaD
Lamotrigine—SCN8A—Developmental Biology—ITGB1—dilated cardiomyopathy	0.000134	0.00184	CbGpPWpGaD
Lamotrigine—Dizziness—Lisinopril—dilated cardiomyopathy	0.000132	0.00129	CcSEcCtD
Lamotrigine—SCN10A—L1CAM interactions—EGFR—dilated cardiomyopathy	0.00013	0.00178	CbGpPWpGaD
Lamotrigine—SCN1A—L1CAM interactions—EGFR—dilated cardiomyopathy	0.00013	0.00178	CbGpPWpGaD
Lamotrigine—UGT1A4—Metabolism—ANKRD1—dilated cardiomyopathy	0.000128	0.00175	CbGpPWpGaD
Lamotrigine—Vomiting—Lisinopril—dilated cardiomyopathy	0.000126	0.00124	CcSEcCtD
Lamotrigine—Rash—Lisinopril—dilated cardiomyopathy	0.000125	0.00123	CcSEcCtD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	0.000125	0.00172	CbGpPWpGaD
Lamotrigine—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000125	0.00122	CcSEcCtD
Lamotrigine—Headache—Lisinopril—dilated cardiomyopathy	0.000125	0.00122	CcSEcCtD
Lamotrigine—SCN9A—Axon guidance—RAC1—dilated cardiomyopathy	0.000122	0.00167	CbGpPWpGaD
Lamotrigine—UGT1A4—Metabolism—TAZ—dilated cardiomyopathy	0.00012	0.00165	CbGpPWpGaD
Lamotrigine—Nausea—Lisinopril—dilated cardiomyopathy	0.000118	0.00115	CcSEcCtD
Lamotrigine—SCN3A—Axon guidance—RAC1—dilated cardiomyopathy	0.000117	0.0016	CbGpPWpGaD
Lamotrigine—SCN8A—Developmental Biology—CD36—dilated cardiomyopathy	0.000114	0.00157	CbGpPWpGaD
Lamotrigine—SCN2A—Axon guidance—RAC1—dilated cardiomyopathy	0.000112	0.00154	CbGpPWpGaD
Lamotrigine—SCN4A—Axon guidance—RAC1—dilated cardiomyopathy	0.000112	0.00154	CbGpPWpGaD
Lamotrigine—UGT1A4—Metabolism—SDHA—dilated cardiomyopathy	0.000109	0.00149	CbGpPWpGaD
Lamotrigine—SCN9A—Developmental Biology—ITGB1—dilated cardiomyopathy	0.000108	0.00149	CbGpPWpGaD
Lamotrigine—SCN10A—Axon guidance—RAC1—dilated cardiomyopathy	0.000108	0.00148	CbGpPWpGaD
Lamotrigine—SCN1A—Axon guidance—RAC1—dilated cardiomyopathy	0.000108	0.00148	CbGpPWpGaD
Lamotrigine—SCN5A—Developmental Biology—PSEN2—dilated cardiomyopathy	0.000108	0.00148	CbGpPWpGaD
Lamotrigine—SCN8A—Developmental Biology—RAC1—dilated cardiomyopathy	0.000108	0.00148	CbGpPWpGaD
Lamotrigine—UGT1A3—Metabolism—ANKRD1—dilated cardiomyopathy	0.000106	0.00146	CbGpPWpGaD
Lamotrigine—ABCB1—Allograft Rejection—AGTR1—dilated cardiomyopathy	0.000106	0.00145	CbGpPWpGaD
Lamotrigine—SCN3A—Developmental Biology—ITGB1—dilated cardiomyopathy	0.000104	0.00142	CbGpPWpGaD
Lamotrigine—SCN8A—Axon guidance—RAF1—dilated cardiomyopathy	0.0001	0.00137	CbGpPWpGaD
Lamotrigine—UGT1A3—Metabolism—TAZ—dilated cardiomyopathy	9.98e-05	0.00137	CbGpPWpGaD
Lamotrigine—SCN2A—Developmental Biology—ITGB1—dilated cardiomyopathy	9.96e-05	0.00137	CbGpPWpGaD
Lamotrigine—SCN4A—Developmental Biology—ITGB1—dilated cardiomyopathy	9.96e-05	0.00137	CbGpPWpGaD
Lamotrigine—SCN1A—Developmental Biology—ITGB1—dilated cardiomyopathy	9.6e-05	0.00132	CbGpPWpGaD
Lamotrigine—SCN10A—Developmental Biology—ITGB1—dilated cardiomyopathy	9.6e-05	0.00132	CbGpPWpGaD
Lamotrigine—SCN5A—Axon guidance—ITGB1—dilated cardiomyopathy	9.46e-05	0.0013	CbGpPWpGaD
Lamotrigine—SCN9A—Developmental Biology—CD36—dilated cardiomyopathy	9.24e-05	0.00127	CbGpPWpGaD
Lamotrigine—SCN5A—L1CAM interactions—EGFR—dilated cardiomyopathy	9.15e-05	0.00125	CbGpPWpGaD
Lamotrigine—UGT1A3—Metabolism—SDHA—dilated cardiomyopathy	9.02e-05	0.00124	CbGpPWpGaD
Lamotrigine—ABCB1—Allograft Rejection—IL10—dilated cardiomyopathy	8.84e-05	0.00121	CbGpPWpGaD
Lamotrigine—SCN3A—Developmental Biology—CD36—dilated cardiomyopathy	8.84e-05	0.00121	CbGpPWpGaD
Lamotrigine—SCN9A—Developmental Biology—RAC1—dilated cardiomyopathy	8.71e-05	0.00119	CbGpPWpGaD
Lamotrigine—SCN4A—Developmental Biology—CD36—dilated cardiomyopathy	8.49e-05	0.00116	CbGpPWpGaD
Lamotrigine—SCN2A—Developmental Biology—CD36—dilated cardiomyopathy	8.49e-05	0.00116	CbGpPWpGaD
Lamotrigine—SCN3A—Developmental Biology—RAC1—dilated cardiomyopathy	8.33e-05	0.00114	CbGpPWpGaD
Lamotrigine—ABCB1—Allograft Rejection—FASLG—dilated cardiomyopathy	8.22e-05	0.00113	CbGpPWpGaD
Lamotrigine—SCN10A—Developmental Biology—CD36—dilated cardiomyopathy	8.19e-05	0.00112	CbGpPWpGaD
Lamotrigine—SCN1A—Developmental Biology—CD36—dilated cardiomyopathy	8.19e-05	0.00112	CbGpPWpGaD
Lamotrigine—SCN9A—Axon guidance—RAF1—dilated cardiomyopathy	8.09e-05	0.00111	CbGpPWpGaD
Lamotrigine—SCN4A—Developmental Biology—RAC1—dilated cardiomyopathy	8e-05	0.0011	CbGpPWpGaD
Lamotrigine—SCN2A—Developmental Biology—RAC1—dilated cardiomyopathy	8e-05	0.0011	CbGpPWpGaD
Lamotrigine—ABCB1—Allograft Rejection—FAS—dilated cardiomyopathy	7.93e-05	0.00109	CbGpPWpGaD
Lamotrigine—SCN3A—Axon guidance—RAF1—dilated cardiomyopathy	7.74e-05	0.00106	CbGpPWpGaD
Lamotrigine—SCN1A—Developmental Biology—RAC1—dilated cardiomyopathy	7.72e-05	0.00106	CbGpPWpGaD
Lamotrigine—SCN10A—Developmental Biology—RAC1—dilated cardiomyopathy	7.72e-05	0.00106	CbGpPWpGaD
Lamotrigine—SCN5A—Axon guidance—RAC1—dilated cardiomyopathy	7.6e-05	0.00104	CbGpPWpGaD
Lamotrigine—SCN2A—Axon guidance—RAF1—dilated cardiomyopathy	7.44e-05	0.00102	CbGpPWpGaD
Lamotrigine—SCN4A—Axon guidance—RAF1—dilated cardiomyopathy	7.44e-05	0.00102	CbGpPWpGaD
Lamotrigine—SCN10A—Axon guidance—RAF1—dilated cardiomyopathy	7.17e-05	0.000984	CbGpPWpGaD
Lamotrigine—SCN1A—Axon guidance—RAF1—dilated cardiomyopathy	7.17e-05	0.000984	CbGpPWpGaD
Lamotrigine—SCN8A—Developmental Biology—RAF1—dilated cardiomyopathy	7.14e-05	0.000979	CbGpPWpGaD
Lamotrigine—SCN8A—Axon guidance—EGFR—dilated cardiomyopathy	6.86e-05	0.000941	CbGpPWpGaD
Lamotrigine—SCN5A—Developmental Biology—ITGB1—dilated cardiomyopathy	6.75e-05	0.000926	CbGpPWpGaD
Lamotrigine—SCN5A—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	5.91e-05	0.00081	CbGpPWpGaD
Lamotrigine—SCN9A—Developmental Biology—RAF1—dilated cardiomyopathy	5.77e-05	0.000792	CbGpPWpGaD
Lamotrigine—SCN5A—Developmental Biology—CD36—dilated cardiomyopathy	5.76e-05	0.00079	CbGpPWpGaD
Lamotrigine—SCN9A—Axon guidance—EGFR—dilated cardiomyopathy	5.55e-05	0.000761	CbGpPWpGaD
Lamotrigine—SCN3A—Developmental Biology—RAF1—dilated cardiomyopathy	5.52e-05	0.000758	CbGpPWpGaD
Lamotrigine—SCN5A—Developmental Biology—RAC1—dilated cardiomyopathy	5.43e-05	0.000744	CbGpPWpGaD
Lamotrigine—SCN3A—Axon guidance—EGFR—dilated cardiomyopathy	5.31e-05	0.000728	CbGpPWpGaD
Lamotrigine—SCN2A—Developmental Biology—RAF1—dilated cardiomyopathy	5.31e-05	0.000728	CbGpPWpGaD
Lamotrigine—SCN4A—Developmental Biology—RAF1—dilated cardiomyopathy	5.31e-05	0.000728	CbGpPWpGaD
Lamotrigine—ABCB1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	5.12e-05	0.000702	CbGpPWpGaD
Lamotrigine—SCN10A—Developmental Biology—RAF1—dilated cardiomyopathy	5.12e-05	0.000702	CbGpPWpGaD
Lamotrigine—SCN1A—Developmental Biology—RAF1—dilated cardiomyopathy	5.12e-05	0.000702	CbGpPWpGaD
Lamotrigine—SCN2A—Axon guidance—EGFR—dilated cardiomyopathy	5.1e-05	0.000699	CbGpPWpGaD
Lamotrigine—SCN4A—Axon guidance—EGFR—dilated cardiomyopathy	5.1e-05	0.000699	CbGpPWpGaD
Lamotrigine—SCN5A—Axon guidance—RAF1—dilated cardiomyopathy	5.04e-05	0.000691	CbGpPWpGaD
Lamotrigine—ABCB1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	4.98e-05	0.000683	CbGpPWpGaD
Lamotrigine—ABCB1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	4.98e-05	0.000683	CbGpPWpGaD
Lamotrigine—SCN1A—Axon guidance—EGFR—dilated cardiomyopathy	4.92e-05	0.000674	CbGpPWpGaD
Lamotrigine—SCN10A—Axon guidance—EGFR—dilated cardiomyopathy	4.92e-05	0.000674	CbGpPWpGaD
Lamotrigine—SCN8A—Developmental Biology—EGFR—dilated cardiomyopathy	4.9e-05	0.000672	CbGpPWpGaD
Lamotrigine—SCN8A—Developmental Biology—TNF—dilated cardiomyopathy	4.66e-05	0.00064	CbGpPWpGaD
Lamotrigine—ABCB1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	4.63e-05	0.000635	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	4.06e-05	0.000556	CbGpPWpGaD
Lamotrigine—SCN9A—Developmental Biology—EGFR—dilated cardiomyopathy	3.96e-05	0.000543	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	3.91e-05	0.000536	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	3.83e-05	0.000526	CbGpPWpGaD
Lamotrigine—SCN3A—Developmental Biology—EGFR—dilated cardiomyopathy	3.79e-05	0.00052	CbGpPWpGaD
Lamotrigine—SCN9A—Developmental Biology—TNF—dilated cardiomyopathy	3.77e-05	0.000517	CbGpPWpGaD
Lamotrigine—SCN2A—Developmental Biology—EGFR—dilated cardiomyopathy	3.64e-05	0.000499	CbGpPWpGaD
Lamotrigine—SCN4A—Developmental Biology—EGFR—dilated cardiomyopathy	3.64e-05	0.000499	CbGpPWpGaD
Lamotrigine—SCN3A—Developmental Biology—TNF—dilated cardiomyopathy	3.61e-05	0.000495	CbGpPWpGaD
Lamotrigine—SCN5A—Developmental Biology—RAF1—dilated cardiomyopathy	3.6e-05	0.000493	CbGpPWpGaD
Lamotrigine—SCN1A—Developmental Biology—EGFR—dilated cardiomyopathy	3.51e-05	0.000481	CbGpPWpGaD
Lamotrigine—SCN10A—Developmental Biology—EGFR—dilated cardiomyopathy	3.51e-05	0.000481	CbGpPWpGaD
Lamotrigine—SCN2A—Developmental Biology—TNF—dilated cardiomyopathy	3.47e-05	0.000475	CbGpPWpGaD
Lamotrigine—SCN4A—Developmental Biology—TNF—dilated cardiomyopathy	3.47e-05	0.000475	CbGpPWpGaD
Lamotrigine—SCN5A—Axon guidance—EGFR—dilated cardiomyopathy	3.46e-05	0.000474	CbGpPWpGaD
Lamotrigine—ABCB1—Allograft Rejection—TNF—dilated cardiomyopathy	3.37e-05	0.000462	CbGpPWpGaD
Lamotrigine—ABCB1—Metabolism—ANKRD1—dilated cardiomyopathy	3.36e-05	0.000461	CbGpPWpGaD
Lamotrigine—SCN10A—Developmental Biology—TNF—dilated cardiomyopathy	3.34e-05	0.000458	CbGpPWpGaD
Lamotrigine—SCN1A—Developmental Biology—TNF—dilated cardiomyopathy	3.34e-05	0.000458	CbGpPWpGaD
Lamotrigine—ABCB1—Metabolism—TAZ—dilated cardiomyopathy	3.16e-05	0.000434	CbGpPWpGaD
Lamotrigine—UGT1A4—Metabolism—GPX1—dilated cardiomyopathy	2.95e-05	0.000405	CbGpPWpGaD
Lamotrigine—UGT1A4—Metabolism—CD36—dilated cardiomyopathy	2.87e-05	0.000394	CbGpPWpGaD
Lamotrigine—ABCB1—Metabolism—SDHA—dilated cardiomyopathy	2.86e-05	0.000392	CbGpPWpGaD
Lamotrigine—UGT1A4—Metabolism—AGT—dilated cardiomyopathy	2.59e-05	0.000355	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	2.54e-05	0.000349	CbGpPWpGaD
Lamotrigine—SCN5A—Developmental Biology—EGFR—dilated cardiomyopathy	2.47e-05	0.000338	CbGpPWpGaD
Lamotrigine—UGT1A3—Metabolism—GPX1—dilated cardiomyopathy	2.45e-05	0.000336	CbGpPWpGaD
Lamotrigine—UGT1A3—Metabolism—CD36—dilated cardiomyopathy	2.39e-05	0.000327	CbGpPWpGaD
Lamotrigine—SCN5A—Developmental Biology—TNF—dilated cardiomyopathy	2.35e-05	0.000322	CbGpPWpGaD
Lamotrigine—UGT1A3—Metabolism—AGT—dilated cardiomyopathy	2.15e-05	0.000295	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	1.74e-05	0.000239	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	1.66e-05	0.000228	CbGpPWpGaD
Lamotrigine—ABCB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.01e-05	0.000138	CbGpPWpGaD
Lamotrigine—ABCB1—Metabolism—GPX1—dilated cardiomyopathy	7.77e-06	0.000107	CbGpPWpGaD
Lamotrigine—ABCB1—Metabolism—CD36—dilated cardiomyopathy	7.57e-06	0.000104	CbGpPWpGaD
Lamotrigine—ABCB1—Metabolism—AGT—dilated cardiomyopathy	6.81e-06	9.35e-05	CbGpPWpGaD
